Stock Ratings / Consumer Discretionary / BYAH / earnings

BNKK (45) CABR (38) YCBD (43) UG (70) ⌘ Pro Terminal →

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) Next Earnings Date & Expected ±12.5% Move

$2.30 +1.71% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.30

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $7.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BYAH Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BYAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, Park Ha Biological Technology Co. Ltd. (Class A) (NASDAQ: BYAH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $2.30 (+1.71% 1D, market cap $7.9M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, BYAH ranks #491 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BYAH compare to BNKK and CABR in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BYAH carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of 94.4%, and ROIC of —. By comparison, BNKK (Bonk Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $9.4M) and CABR (Caring Brands Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BYAH?

▼

Per BYAH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0001986247), Park Ha Biological Technology Co. Ltd. (Class A) generated $2.5M in revenue (+6.0% YoY), -$24.4M in net income, and $85.9K in free cash flow against $6.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.30 (+0.12%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 3.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BYAH)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (57/100 Composite)

🔍 WHY BYAH SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+14/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 3.4% FCF Margin ($85.9K FCF) & 94.4% Gross Margin

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 42.3 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Dilution Drag (+1.36% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$2.53-13% Next Q

Q2 (-2Q)

Grade C+$2.20+5.5% Next Q

Q3 (-1Q)

Grade C$2.32-0.9% Next Q

Current

Grade D+$2.30-0.2% Hist 90D α

Trajectory: C+ (65) → D+ (57)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BYAH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 57/100 (D+) score, BYAH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($2.49) or 200D SMA ($10.86) invalidates the momentum regime and cuts Target Base ($2.29) toward Bear Floor ($1.79).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BYAH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BYAH Beats Next Quarter EPS Consensus (Jan 29, 2027) & Holds Above 200D SMA”

YES 57%NO 43%Trade / Inspect Odds →

NEXT EST. WINDOW: Jan 29, 2027 (~88 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.29 Expected Swing

MODEL EARNINGS SETUP GAUGE

BYAH Quantitative Pre-Earnings Setup: 57/100

Trailing EPS: $4.25 • YoY Revenue Growth: 6%

Model Bullish Setup (57/100)Model Risk Weight (43/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-10-31	$2.5M	-$24.4M	$85.9K	94.4%
FY 2024	2024-10-31	$2.4M	$478.6K	$960.5K	91.8%
FY 2023	2023-10-31	$2.5M	$852.0K	$126.5K	92%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BYAH)

✓Walkthrough of BYAH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BYAH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -73.74%▲ RESISTANCE BREAKOUT

2026-10-30O $2.21H $2.31L $2.15C $2.30VOL 15.4K

RES: $0.88SUP: $1.60SMA50: $2.49SMA200: $10.86

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BYAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BYAH Butterfly Map → + Track BYAH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BYAH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BYAH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BYAH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BYAH)

Consumer Discretionary Rank #491 of 1011 ⚔️ BNKK vs BYAH Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BYAH vs. BNKK, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) ranks #491 by composite RQD confidence (57/100, grade D+) and #945 by equity capitalization ($7.9M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with BYAH at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BYAH ACTIVE Park Ha Biological Technology Co. Ltd. (Class A)	D+	57/100	—	94.4%	—	+1.71%	$7.9M	Benchmark Subject
BNKK Bonk Inc.	D	45/100	—	58.5%	-35.0%	-2.48%	$9.4M	/bnkk-vs-byah →
CABR Caring Brands Inc.	D-	38/100	—	55.6%	-35.0%	-4.46%	$11.2M	/cabr-vs-byah →
YCBD cbdMD Inc.	D-	43/100	—	62.4%	-30.4%	+4.56%	$4.3M	/ycbd-vs-byah →
UG United-Guardian Inc.	B-	70/100	14.5x	—	17.8%	-1.19%	$30.6M	/ug-vs-byah →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-10-31 • CIK 0001986247

In its most recent audited fiscal period (FY2025, filed 2025-10-31), Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) reported GAAP revenue of $2.5M (+6.0% vs. FY2024 revenue of $2.4M , and +2.7% cumulative change since FY2023) , GAAP net income of -$24.4M, operating cash flow of $85.9K, and free cash flow of $85.9K (-91.1% YoY). On the balance sheet, BYAH closed FY2025 with $6.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-10-31	$2.5M	-$24.4M	$85.9K	$85.9K	$6.0M	—
FY2024 (FY)	2024-10-31	$2.4M	$478.6K	$960.5K	$960.5K	—	—
FY2023 (FY)	2023-10-31	$2.5M	$852.0K	$126.5K	$126.5K	—	—

3. BYAH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BYAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BYAH compare to BNKK and CABR in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for BYAH?

Where is BYAH trading relative to its 50-day, 200-day, and 52-week technical levels?

BYAH last traded at $2.30 (+1.71% on volume of 2,204 shares), positioning the stock -7.63% below its 50-day simple moving average ($2.49) and -78.82% below its 200-day simple moving average ($10.86). Across its 52-week range of $1.90 to $158.00, BYAH sits at the 0.3% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.01 to $2.59).

BYAH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is BYAH's next earnings date?

Based on SEC filing cadence, Park Ha Biological Technology Co. Ltd. (Class A) (BYAH)'s next quarterly reporting window is estimated around Jan 29, 2027.

How much is BYAH stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for BYAH, spanning a range between $2.01 and $2.59.

Direct Sub-Reports: BYAH RQD Cockpit BYAH 12M Forecast BYAH Earnings & Move BYAH Dividends & DRIP BYAH Insiders & 13F BYAH Whale Options BYAH Profit Sankey BYAH News & Why